| Literature DB >> 23722085 |
Shanmugam Saravanan1, Vidya Madhavan, Vijayakumar Velu, Kailapuri G Murugavel, Greer Waldrop, Sunil S Solomon, Pachamuthu Balakrishnan, Nagalingeswaran Kumarasamy, Davey M Smith, Kenneth H Mayer, Suniti Solomon, Sadras P Thyagarajan.
Abstract
We conducted a study to investigate HIV and hepatitis delta virus (HDV) coinfection among patients with chronic hepatitis B virus (HBV) infection and the triple infection's (HIV/HBV/HDV) clinical implications in India, an intermediate HBV endemic region, with an estimated HIV-positive population of 2.5 million. A total of 450 patients (men: 270; women: 180) with chronic HBV infections and 135 healthy volunteers were screened for HIV and HDV. The incidence of the triple infection was low (4 [0.8%]) compared with dual infections of HIV-1/HBV (7 [1.5%]) and HBV/HDV (22[4.8%]). Among 21- to 40-year-olds, HBV/HDV coinfection (45.8%) and HBV/HDV/HIV-1 triple infection was predominant (75%). Among 11 patients coinfected with HIV-1/HBV, 4 (36%) were tri-infected and were also associated with chronic hepatitis and cirrhosis. The HDV coinfection was higher among patients coinfected with HBV/HIV-1, despite the declining trend in HDV infection among HIV-negative patients, as previously reported. Thus, it is important to assess the impact of HIV, chronic HBV, and HDV tri-infection in India.Entities:
Keywords: coinfection in India; hepatitis B virus (HBV); hepatitis delta virus (HDV); human immunodeficiency virus (HIV)
Mesh:
Year: 2013 PMID: 23722085 PMCID: PMC4114572 DOI: 10.1177/2325957413488166
Source DB: PubMed Journal: J Int Assoc Provid AIDS Care ISSN: 2325-9574